The Canadian animal health wing of drug maker Pfizer has picked up registration for a new immunization against porcine circovirus (PCV) in pigs at least three weeks old.
The product, named Fostera PCV, is labeled for use as “an aid in preventing viremia and an aid in the control of PCV2-related lymphoid depletion.”
The new product, Pfizer said Thursday, “provides four months of immunity against PCV in a single two-millilitre dose.”
Fostera “offers Canadian swine veterinarians and producers a new choice for long-lasting, consistent protection against PCV,” Pfizer Animal Health’s swine business unit director Walter Heuser said in a release.
Heuser tied the new product’s release in with a “new one-day-of-age claim for RespiSure-One” and billed the use of both products as “an innovative mycoplasma and circovirus vaccination program which gives veterinarians and their producers the flexibility to vaccinate for these key pathogens before disease challenge.”
Fostera, Pfizer said, will be available “exclusively through Canadian veterinarians.”